Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction

被引:31
作者
Vanderheyden, Marc [1 ,2 ]
Vercauteren, Steven [1 ]
Mansour, Samer [1 ]
Delrue, Leen [2 ]
Vandekerckhove, Bart [3 ,4 ]
Heyndrickx, Guy R. [1 ]
Van Haute, Inge [3 ]
De Bruyne, Bernard [1 ]
Timmermans, Frank [4 ]
Wijns, William [1 ]
Bartunek, Jozef [1 ,2 ]
机构
[1] Onze Lieve Vrouw Hosp, Ctr Cardiovasc, B-9300 Aalst, Belgium
[2] Onze Lieve Vrouw Hosp, Mol Cardiol Unit, Aalst, Belgium
[3] Flemish Red Cross, Cell Therapy Unit, Ghent, Belgium
[4] Univ Ghent, Ghent, Belgium
关键词
myocardial infarction; coronary artery diseases; bone marrow stem cells; atherosclerosis;
D O I
10.3727/096368907783338244
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bone marrow (BM) cells may interact with coronary endothelium and modulate coronary atherosclerosis. We investigated the time course of coronary luminal loss and changes in conductance after intracoronary injection of enriched hematopoietic BM stem cells in patients with previous myocardial infarction (MI). Among 24 patients with acute MI, 13 were randomized to early (<7 days) and 11 to late (4 months) intracoronary injection of CD133(+) cells after the infarction. Segmental quantitative coronary angiography and fractional flow reserve (FFR) measurements of the infarct-related (IR) artery (A) and contralateral artery (control) were performed. In the early group, at 4 months, cumulative luminal loss (LL) of the minimal luminal diameter (MLD) of the IRA distal to the stented segment was -0.39 (-0.51-0.10) mm (p < 0.05 vs. control). There was no further change in LL between 4 and 8 months [-0.09 (-0.26-0.15) mm]. In parallel, FFR decreased at 4 months [-0.16 (-0.26-0.001), p < 0.05 vs. control] but slightly increased from 4 to 8 months follow-up [+0.05 (-0.10-0.09)]. In the late group, LL of the MLD of the IRA distal to the stented segments was -0.12 (-0.47-0.07) mm (NS vs. control) at 4 months and further -0.07 (-0.25-0.05) mm (NS) between 4 and 8 months. At 8 months, the total LL of the MLD in the early and late group was only slightly higher compared to control [-0.34 (-0.48--0.16), -0.36 (-0.69--0.09), and -0.12 (-0.39-0.05) mm, respectively, NS]. Early intracoronary administration of hematopoietic BM stem cells in patients with previous MI is associated with accelerated luminal loss and reduced conductance of the infarct-related artery.
引用
收藏
页码:919 / 925
页数:7
相关论文
共 22 条
[1]   Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction - Feasibility and safety [J].
Bartunek, J ;
Vanderheyden, M ;
Vandekerckhove, B ;
Mansour, S ;
De Bruyne, B ;
De Bondt, P ;
Van Haute, I ;
Lootens, N ;
Heyndrickx, G ;
Wijns, W .
CIRCULATION, 2005, 112 (09) :I178-I183
[2]   AC133 expression in human stem cells [J].
Bhatia, M .
LEUKEMIA, 2001, 15 (11) :1685-1688
[3]   Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography [J].
De Bruyne, B ;
Hersbach, F ;
Pijls, NHJ ;
Bartunek, J ;
Bech, JW ;
Heyndrickx, GR ;
Gould, KL ;
Wijns, W .
CIRCULATION, 2001, 104 (20) :2401-2406
[4]   Fractional flow reserve in patients with prior myocardial infarction [J].
De Bruyne, B ;
Pijls, NHJ ;
Bartunek, J ;
Kulecki, K ;
Bech, JW ;
De Winter, H ;
Van Crombrugge, P ;
Heyndrickx, GR ;
Wijns, W .
CIRCULATION, 2001, 104 (02) :157-162
[5]   BASIC FIBROBLAST GROWTH-FACTOR ENHANCES THE COUPLING OF INTIMAL HYPERPLASIA AND PROLIFERATION OF VASA VASORUM IN INJURED RAT ARTERIES [J].
EDELMAN, ER ;
NUGENT, MA ;
SMITH, LT ;
KARNOVSKY, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :465-473
[6]   Janus phenomenon - The interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis [J].
Epstein, SE ;
Stabile, E ;
Kinnaird, T ;
Lee, CW ;
Clavijo, L ;
Burnett, MS .
CIRCULATION, 2004, 109 (23) :2826-2831
[7]   Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction [J].
Fernández-Avilés, F ;
San Román, JA ;
García- Frade, J ;
Fernández, ME ;
Peñarrubia, MJ ;
de la Fuente, L ;
Gómez-Bueno, M ;
Cantalapiedra, A ;
Fernández, J ;
Gutierrez, O ;
Sánchez, PL ;
Hernández, C ;
Sanz, R ;
García-Sancho, J ;
Sánchez, A .
CIRCULATION RESEARCH, 2004, 95 (07) :742-748
[8]   Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice [J].
George, J ;
Afek, A ;
Abashidze, A ;
Shmilovich, H ;
Deutsch, V ;
Kopolovich, J ;
Miller, H ;
Keren, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) :2636-2641
[9]   Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells [J].
Hu, YH ;
Davison, F ;
Zhang, ZY ;
Xu, QB .
CIRCULATION, 2003, 108 (25) :3122-3127
[10]   Transplant graft vasculopathy - A dark side of bone marrow stem cells? [J].
Ii, M ;
Losordo, DW .
CIRCULATION, 2003, 108 (25) :3056-3058